Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00265538 · ClinicalTrials.gov registry record · NA
Implementing Evidence Based Treatment of Hypertension
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 834
- Enrollment target
NCT00265538: Completed NA study, sponsored by VA Office of Research and Development.
NCT00265538 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 834 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (41% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00265538, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 834 participants
- Enrollment target
Study Summary
This study examines the use of patient initiated discussions of blood pressure medication in the primary care setting. Additionally, this study examines different levels of patient incentive(s) to initiate discussions with providers including information only, information plus a financial incentive and reimbursement for 6 months of copay, and information/monetary incentive plus a reminder call prior to the index visit. Patient opinions about doctor/patient relationships will be assessed. Provider attitudes and prescribing behaviors will be analyzed as well.
Primary Outcome
Reported in 2 sub-groups: Subgroup 1 not at BP goal; Subgroup 2 at BP goal but taking a calcium channel blocker (see pre-specified sub group analysis below).
Interventions
- BEHAVIORAL Patient educational letter to engage provider in hypertension rx discussion
- BEHAVIORAL Financial incentive (Arms B and C) and health educator phone call (Arm C)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 834 participants |
| Start Date | 2006-07 |
| Est. Completion | 2009-08 |
| Phase | NA |
What the finished NCT00265538 record still lists
NCT00265538 is an interventional study that assigns participants to a tested intervention. The registered 834 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (41% lower).
The record links to 0 conditions, and to 2 interventions - of which Patient educational letter to engage provider in hypertension rx discussion is the first listed.
NCT00265538 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00265538 about?
NCT00265538 is a clinical study titled "Implementing Evidence Based Treatment of Hypertension". This study examines the use of patient initiated discussions of blood pressure medication in the primary care setting. Additionally, this study examines different levels of patient incentive(s) to initiate discussions with providers including information only, information plus a financial incentive ...
What is the current status of trial NCT00265538?
This trial is currently completed. It is a NA study. The enrollment target is 834 participants. The study started on 2006-07. Estimated completion is 2009-08.
What interventions are being tested in trial NCT00265538?
The interventions under investigation include: Patient educational letter to engage provider in hypertension rx discussion (BEHAVIORAL), Financial incentive (Arms B and C) and health educator phone call (Arm C) (BEHAVIORAL).
Who is sponsoring clinical trial NCT00265538?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00265538's enrollment target sits among peer trials
834 134th of 2000 higher than 1,867 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03670524 · 835 participants · NA
Health, Environment and Action in Louisville (HEAL) Green Heart Louisville Project
- NCT02118467 · 836 participants · Phase 4
Vasoactive Drugs in Intensive Care Unit
- NCT06910553 · 832 participants
IBD Pregnancy Registry
- NCT07089706 · 832 participants · Phase 4
A Study to Evaluate the Immunogenicity and Safety of mRNA-1283 COVID-19 Variant-containing Formulations
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia